Epidemiology and treatment of acute promyelocytic leukemia in Latin America (2011)
- Authors:
- Autor USP: REGO, EDUARDO MAGALHÃES - FMRP
- Unidade: FMRP
- DOI: 10.4084/MJHID.2011.049
- Subjects: LEUCEMIA MIELOIDE AGUDA; EPIDEMIOLOGIA
- Language: Inglês
- Imprenta:
- Source:
- Título: Mediterranean Journal of Hematology and Infectious Diseases
- ISSN: 2035-3006
- Volume/Número/Paginação/Ano: v. 3, n. 1, art. e2011049, 2011
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
REGO, Eduardo Magalhães e JÁCOMO, Rafael Henriques. Epidemiology and treatment of acute promyelocytic leukemia in Latin America. Mediterranean Journal of Hematology and Infectious Diseases, v. 3, n. 1, 2011Tradução . . Disponível em: https://doi.org/10.4084/MJHID.2011.049. Acesso em: 27 jan. 2026. -
APA
Rego, E. M., & Jácomo, R. H. (2011). Epidemiology and treatment of acute promyelocytic leukemia in Latin America. Mediterranean Journal of Hematology and Infectious Diseases, 3( 1). doi:10.4084/MJHID.2011.049 -
NLM
Rego EM, Jácomo RH. Epidemiology and treatment of acute promyelocytic leukemia in Latin America [Internet]. Mediterranean Journal of Hematology and Infectious Diseases. 2011 ; 3( 1):[citado 2026 jan. 27 ] Available from: https://doi.org/10.4084/MJHID.2011.049 -
Vancouver
Rego EM, Jácomo RH. Epidemiology and treatment of acute promyelocytic leukemia in Latin America [Internet]. Mediterranean Journal of Hematology and Infectious Diseases. 2011 ; 3( 1):[citado 2026 jan. 27 ] Available from: https://doi.org/10.4084/MJHID.2011.049 - Evaluation of the European LeukemiaNet recommendations for predicting outcomes of patients with acute myeloid leukemia treated in low- and middle-income countries (LMIC): A Brazilian experience
- Thalidomide plus dexamethasone as a maintenance therapy after autologous hematopoietic stem cell transplantation improves progression-free survival in multiple myeloma
- Combining gene mutation with gene expression data improves outcomes prediction in acute promyelocytic leukemia
- Identification of myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia
- Granulocyte colony-stimulating factor and leukemogenesis
- Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APL
- Association between the TP53 Arg72Pro polymorphism and clinical outcomes in acute myeloid leukemia
- Hematopoese: cinética de hemácias, neutrófilos e plaquetas
- Clinical impact of BAALC expression in high-risk acute promyelocytic leukemia
- Leukemia with distinct phenotypes in transgenic mice expressing PML/RAR'alfa', PLZF/RAR'alfa' or NPM/RAR'alfa'
Informações sobre o DOI: 10.4084/MJHID.2011.049 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
